Debra Patt, MD, MPH, MBA


Influence of Cardiotoxic Risk on Treatment Choice in Adult Cancers

May 26, 2015

With the explosion of new therapies in cancer care, the risk of each new therapy must be clearly understood prior to making treatment decisions with patients. Data from clinical trials alone are insufficient to educate these treatment choices, and real-world evidence from higher-risk populations should be generated to inform these treatment decisions.